Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML casesSchoch, Claudia ; Schnittger, Susanne ; Klaus, Mirjam ; Kern, Wolfgang ; Hiddemann, Wolfgang ; Haferlach, TorstenBlood, 2003-10, Vol.102 (7), p.2395-2402 [Periódico revisado por pares]Washington, DC: Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemiaSpinelli, Orietta ; Peruta, Barbara ; Tosi, Manuela ; Guerini, Vittoria ; Salvi, Anna ; Zanotti, Maria Cristina ; Oldani, Elena ; Grassi, Anna ; Intermesoli, Tamara ; Mico, Caterina ; Rossi, Giuseppe ; Fabris, Pietro ; Lambertenghi-Deliliers, Giorgio ; Angelucci, Emanuele ; Barbui, Tiziano ; Bassan, Renato ; Rambaldi, AlessandroHaematologica (Roma), 2007-05, Vol.92 (5), p.612-618 [Periódico revisado por pares]Pavia: HaematologicaTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapyGardner, Rebecca ; Wu, David ; Cherian, Sindhu ; Fang, Min ; Hanafi, Laïla-Aïcha ; Finney, Olivia ; Smithers, Hannah ; Jensen, Michael C. ; Riddell, Stanley R. ; Maloney, David G. ; Turtle, Cameron J.Blood, 2016-05, Vol.127 (20), p.2406-2410 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Mouse models of MLL leukemia: recapitulating the human diseaseMilne, Thomas A.Blood, 2017-04, Vol.129 (16), p.2217-2223 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Supplementing leukemia therapyFoley, John F.Science signaling, 2018-07, Vol.11 (541) [Periódico revisado por pares]Washington: The American Association for the Advancement of ScienceTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyCruz, Conrad Russell Y. ; Micklethwaite, Kenneth P. ; Savoldo, Barbara ; Ramos, Carlos A. ; Lam, Sharon ; Ku, Stephanie ; Diouf, Oumar ; Liu, Enli ; Barrett, A. John ; Ito, Sawa ; Shpall, Elizabeth J. ; Krance, Robert A. ; Kamble, Rammurti T. ; Carrum, George ; Hosing, Chitra M. ; Gee, Adrian P. ; Mei, Zhuyong ; Grilley, Bambi J. ; Heslop, Helen E. ; Rooney, Cliona M. ; Brenner, Malcolm K. ; Bollard, Catherine M. ; Dotti, GianpietroBlood, 2013-10, Vol.122 (17), p.2965-2973 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Jennifer KernahanReid, Mike ; Craft, AlanBMJ (Online), 2023-09, Vol.382, p.p2167 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic LineagesLee, Winston Y ; Weinberg, Olga K ; Pinkus, Geraldine SAmerican journal of clinical pathology, 2017-04, Vol.147 (4), p.420-426 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cellsKaterndahl, Casey D S ; Rogers, Olivia R S ; Day, Ryan B ; Xu, Ziheng ; Helton, Nichole M ; Ramakrishnan, Sai Mukund ; Miller, Christopher A ; Ley, Timothy JProceedings of the National Academy of Sciences - PNAS, 2024-04, Vol.121 (18), p.e2317690121-e2317690121 [Periódico revisado por pares]United States: National Academy of SciencesTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trialLambert, Juliette ; Pautas, Cécile ; Terré, Christine ; Raffoux, Emmanuel ; Turlure, Pascal ; Caillot, Denis ; Legrand, Ollivier ; Thomas, Xavier ; Gardin, Claude ; Gogat-Marchant, Karïn ; Rubin, Stephen D ; Benner, Rebecca J ; Bousset, Pierre ; Preudhomme, Claude ; Chevret, Sylvie ; Dombret, Herve ; Castaigne, SylvieHaematologica (Roma), 2019-01, Vol.104 (1), p.113-119 [Periódico revisado por pares]Italy: Ferrata Storti FoundationTexto completo disponível |